GSK India appoints Mr Sridhar Venkatesh as Managing Director & VP Medical Dialogues Bureau4 March 2020 5:43 PM ISTMumbai: Mr Sridhar Venkatesh has been appointed as Managing Director & VP of GSK India effective 1 April 2020. He succeeds Mr Annaswamy Vaidheesh...
EMA accepts GSK filing for Trelegy Ellipta use in adults with asthma Medical Dialogues Bureau4 March 2020 10:15 AM ISTonce-daily single inhaler triple therapy available for asthma and COPD if approved
GSK launches Iodex UltraGel Medical Dialogues Bureau31 Jan 2020 1:23 PM ISTNew Delhi – GSK announced the launch of Iodex UltraGel, a new age clinically proven gel-based body pain solution. Backed by science, the new...
More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 2:48 PM ISTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
GSK Benlysta gets European nod for treatment of children with lupus Medical Dialogues Bureau4 Nov 2019 9:15 AM ISTNew Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
GSK Pharma reports Q2 profit at Rs 503 crore Medical Dialogues Bureau1 Nov 2019 9:15 AM ISTGSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation...
GSK lifts annual profit forecast after third quarter beat on vaccines strength Medical Dialogues Bureau31 Oct 2019 9:00 AM ISTGSK now expects full-year profit to be roughly flat compared to last year at constant currency, up from a previous forecast of a fall of 3% to 5%.New...
GSK ovarian cancer drug Zejula gets USFDA nod for wider use Medical Dialogues Bureau24 Oct 2019 10:00 AM ISTZejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion Medical Dialogues Bureau22 Oct 2019 10:00 AM ISTThe sale of GSK's anti-rabies treatment Rabipur and Encepur, used for the prevention of tick-borne encephalitis, to the Denmark-based biotechnology...
GSK collaborates with Lyell Immunopharma on cancer cell therapies Medical Dialogues Bureau12 Oct 2019 9:15 AM ISTCombining GSK plc's strong cell and gene therapy programmes with Lyell's technologies may allow the joint research team to maximize the activity and...
Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure Medical Dialogues Bureau9 Oct 2019 9:30 AM ISTGSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the...
GSK fights bid to strike new Zofran preemption evidence Medical Dialogues Bureau20 Sept 2019 9:00 AM ISTU.S. District Judge F. Dennis Saylor during a hearing in Boston asked why some of GSK's witnesses should be allowed to put forward new opinions to...
